ReS10-T program (reMYND/Roche)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameReS10-T program (reMYND/Roche)
Drug Alias NameReS10-T compounds (reMYND/Roche)ReS10-TReS10-T Compounds (reMYND)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRemynd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding AgRemynd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A